Universal Health Services, Inc. Class B Q2 2026 earnings show adjusted EPS of $5.98, up 12% YoY, but cash flow declines raise concerns amid guidance cuts.
Universal Health Services, Inc. Class B reported Q2 2026 adjusted earnings per share of $5.98, up 12% year-over-year, surpassing the consensus estimate of $5.76. Despite the earnings beat, the company signaled concerns about slower-than-expected ramp-ups at new facilities and rising professional and general liability costs, leading to a downward adjustment in its full-year guidance.
Key Takeaways
- Adjusted EPS increased to $5.98, a 12% growth year-over-year, beating the consensus of $5.76.
- Adjusted EBITDA decreased to $678 million, falling short of internal expectations due to several adverse factors totaling approximately $63 million.
- Acute care admissions rose 2.9% year-over-year, while same facility surgeries saw a slight decline of 0.8%.
- Guidance Update: The company lowered its full-year adjusted EBITDA less NCI forecast by $50 million, now expecting $2.61 billion to $2.72 billion.
- Cash Flow from operating activities dropped significantly to $44.3 million compared to $549 million in the same quarter last year.
Adjusted EPS Growth Signals Operational Resilience
Adjusted EPS for Q2 2026 rose to $5.98, reflecting a robust 12% increase from $5.34 in Q2 2025. Despite this positive performance, adjusted EBITDA, at $678 million, fell short of internal expectations primarily due to a $100 million out-of-period Medicaid benefit from Florida and operational challenges in new facilities. The following table summarizes key financial metrics:
| Metric | Q2 2026 | YoY | QoQ |
|---|---|---|---|
| Adjusted EPS | $5.98 | +12% | N/A |
| Adjusted EBITDA | $678M | +5% | N/A |
| Acute Care Admissions Growth | 2.9% | +2.9% | N/A |
| Cash from Operations | $44.3M | -92% | N/A |
Guidance Cut Reflects New Facility Challenges
Management reduced its full-year guidance for adjusted EBITDA less NCI to a range of $2.61 billion to $2.72 billion, down by approximately $50 million from the previous midpoint of $2.66 billion. This outlook is influenced by several factors:
- Increased Medicaid supplemental funding is now projected at $1.5 billion for the year, a $150 million increase.
- Operational losses at the Cedar Hill Medical Center and the behavioral health facility in Texas, which is undergoing recertification, are expected to impact earnings significantly. The Texas facility alone is anticipated to incur losses of $5 to $10 million per quarter through 2026.
- Higher liability reserves, which increased professional and general liability expenses by approximately $50 million, were prompted by rising claim severity across the sector.
Cash Flow Decline Raises Concerns
The company's cash flow from operating activities took a substantial hit, dropping to $44.3 million from $549 million a year earlier. This decline raises concerns about liquidity, especially given the increased capital expenditures of $228 million during the quarter related to new facility openings. While the company remains committed to its stock buyback program, having repurchased $320 million worth of shares in Q2, the capital allocation strategy may require reevaluation in light of the current financial pressures.
Analyst Q&A Highlights Concerns Over Volume Growth
During the Q&A session, analysts expressed concerns about volume growth in both the acute care and behavioral health segments. Management acknowledged a trend of elective procedures shifting to outpatient settings, impacting inpatient admissions. They reaffirmed that while acute care admissions grew by 2.9%, the overall performance was not as robust as expected, particularly in surgical volumes, which declined by 0.8% year-over-year. Analysts noted the potential for continued pressure from outpatient trends and asked how the company plans to adapt.
Management indicated that investments in technology and outpatient capacity, including the acquisition of Talkspace, should help capture growing demand for outpatient services.
Frequently Asked Questions
Did Universal Health Services, Inc. Class B beat earnings estimates in Q2 2026?
Yes, UHS reported adjusted EPS of $5.98, which exceeded the consensus estimate of $5.76 by 22 cents.
What was the adjusted EBITDA for UHS in Q2 2026?
The adjusted EBITDA for Q2 2026 was $678 million, which reflects a 5% year-over-year growth but fell short of internal expectations.
What factors led to the guidance cut for full-year EBITDA?
The guidance cut was primarily due to expected operational losses at the Cedar Hill Medical Center and increased professional and general liability expenses, totaling about $50 million in adverse impacts.
How did cash flow change compared to the previous year?
Cash generated from operating activities significantly decreased to $44.3 million in Q2 2026, down from $549 million in Q2 2025, indicating liquidity challenges.
What is the outlook for the behavioral health segment?
The behavioral health segment's adjusted patient days grew by 1.4% year-over-year, but management revised full-year volume growth guidance down to 1% to 2%, reflecting ongoing pressures in the market.
The upcoming quarters will be critical for UHS as they navigate these challenges and adjust their strategies accordingly.
This analysis is based on public earnings call materials and is not investment advice.
